Surgical Glue Market Report Scope and Overview:

The Surgical Glue Market was valued at USD 3.15 Billion in 2025 and is projected to reach USD 6.13 Billion by 2035, registering a CAGR of 6.9% from 2026 to 2035.

The Surgical Glue Market transformed wound closure and hemostasis processes through providing surgeons with cyanoacrylates, fibrins, and synthetic polymers for incision sealing, hemorrhage control, and reduced dependence on suturing and stapling techniques. The market is characterized by rising adoption of tissue adhesives in minimally invasive and robotic-assisted surgery, growing preference for bioresorbable internal adhesives over traditional biologic glues, and expanding use in cardiovascular, orthopedic, and cosmetic procedures. Significant growth is being witnessed in the deployment of room-temperature-stable sealants, sensor-enabled dispensing devices and synthetic hemostatic matrices, as hospitals and surgical centers continue investing in adhesive technology that shortens operating time, lowers infection risk and improves patient recovery.

Baxter International launched its room-temperature-stable Hemopatch Sealing Hemostat in 2025, eliminating cold-chain storage requirements for its collagen-based sealing patch and reflecting the industry's broader shift toward more accessible, ambulatory-friendly adhesive formulations.

Surgical Glue Market Trends

• Rising adoption of tissue adhesives continues expanding across minimally invasive and robotic-assisted procedures.

• Growing preference for bioresorbable internal adhesives continues displacing traditional biologic glue formulations.

• Expanding room-temperature-stable sealant availability continues improving accessibility across ambulatory surgical centers.

• Increasing use of synthetic cyanoacrylate adhesives continues driving faster, sutureless cosmetic wound closure.

• Rising strategic consolidation among adhesive and hemostat suppliers continues reshaping the competitive vendor landscape.

U.S. Surgical Glue Market Outlook

The U.S. Surgical Glue Market was valued at approximately USD 1.08 Billion in 2025 and is projected to reach approximately USD 2.03 Billion by 2035, registering a CAGR of approximately 6.5% from 2026 to 2035.

Demand across the United States continued to be shaped by the high volume of minimally invasive surgical procedures, alongside a dense concentration of ambulatory surgical centers driving demand for fast, reliable wound closure alternatives to sutures. Rising deployment of bioresorbable internal adhesives and room-temperature-stable sealants by leading hospital networks continued reinforcing the country's position as the largest and most technologically advanced surgical glue market. Increasing deployment in cosmetic and outpatient surgery settings has introduced additional layers of ongoing domestic demand, where rising same-day procedure numbers have increasingly leveraged sutures-free wound closure technology. Continued expansion of hospital outpatient departments and freestanding surgical facilities further sustained instrument and adhesive purchasing nationwide.

Baxter International completed its acquisition of PerClot powdered hemostat assets from Artivion in 2024, broadening its room-temperature-stable hemostat and sealant portfolio to strengthen its position across American ambulatory surgical centers.

Surgical Glue Market Segment Analysis

• By Product Type, Cyanoacrylate-Based Adhesives segment dominated the Surgical Glue Market in 2025 with 42% share; Synthetic and Semi-Synthetic Adhesives segment is the fastest growing segment with a CAGR of approximately 9.6%.

• By Application, General Surgery segment dominated the Surgical Glue Market in 2025 with 34% share; Cosmetic Surgery segment is the fastest growing segment with a CAGR of approximately 10.4%.

• By Wound Type, External Wound Closure segment dominated the Surgical Glue Market in 2025 with 61% share; Internal Tissue Sealing segment is the fastest growing segment with a CAGR of approximately 9.2%.

• By End-User, Hospitals segment dominated the Surgical Glue Market in 2025 with 57% share; Ambulatory Surgical Centers segment is the fastest growing segment with a CAGR of approximately 9.9%.

By Product Type: Cyanoacrylate Adhesives Lead, Synthetic Formulations Emerge as Fastest-Growing Segment

The Cyanoacrylate-Based Adhesives segment dominated the Surgical Glue Market in 2025, driven by their role as the fast-curing, easy-to-apply option preferred for topical skin closure across general, dermatologic and emergency wound care settings. Broad regulatory approval and low per-procedure cost sustained steady replacement demand across high-volume outpatient and hospital settings. Growing use of octyl and butyl cyanoacrylate variants for cosmetic and pediatric wound closure reinforced this segment as the single largest contributor to total market spending throughout the base year, with expanding emergency department adoption further sustaining unit volumes.

The Synthetic and Semi-Synthetic Adhesives segment is the fastest growing in the Surgical Glue Market owing to rising demand for engineered, virus-risk-free alternatives to biologic fibrin and collagen-based products in high-value surgical specialties. Growing clinical evidence supporting synthetic polyethylene glycol and urethane-based internal adhesives continues expanding adoption among cardiovascular and neurosurgical procedures. Rising vendor investment in bioresorbable polymer chemistry is accelerating this segment's growth trajectory across hospitals worldwide, as synthetic formulations increasingly displace biologic adhesives in premium surgical specialties.

By Application: General Surgery Dominates, Cosmetic Surgery Grows Fastest

General Surgery segment emerged as the dominant segment within the Surgical Glue Market based on the fundamental application of tissue glue products in abdominal incision closures for general surgery, laparoscopy, and gastrointestinal procedures where minimal tissue trauma and decreased procedural operating times were critical benefits offered to surgeons. Continued expansion of laparoscopic and robotic-assisted general surgery reinforced this segment's dominant position throughout the base year, supported by growing hospital preference for adhesive-assisted mesh fixation techniques.

The Cosmetic Surgery segment is experiencing rapid growth due to the increasing deployment of advanced cyanoacrylate film technologies among cosmetic surgeons to reduce the visibility of surgical scars post-aesthetic surgeries. Consumer demand for minimally-invasive, stitch-free wound closure methods continues expanding the patient population eligible for the treatment modality. Rapid deployment of cyanoacrylate tissue adhesive solutions across outpatient cosmetic centers and elective surgical facilities has been accelerated by rising demand for minimal-scar aesthetic results fueled by social media marketing trends.

By Wound Type: External Closure Dominates, Internal Sealing Grows Fastest

The External Wound Closure segment dominated the Surgical Glue Market due to being widely used in closing skin incisions and lacerations compared with competing technologies for tissue adhesion. Extensive regulatory precedent and broad product availability across emergency and outpatient settings sustained external closure's dominant position throughout the base year.  Ongoing innovation focused around development of flexible, waterproof adhesives allowed this segment to maintain its dominant share of overall market revenues during the base year.

The Internal Tissue Sealing segment is the fastest growing due to rising demand for adhesives that reduce fluid accumulation and eliminate surgical drains following abdominoplasty, cardiovascular, and reconstructive procedures. Growing clinical evidence supporting internal-use bioresorbable adhesives continues expanding adoption among plastic and cardiac surgery programs. Rising vendor investment in internal-use regulatory approvals is accelerating this category's transition from niche application toward broader mainstream surgical adoption, particularly across plastic surgery and bariatric procedures.

By End-User: Hospitals Dominate, Ambulatory Centers Grow Fastest

The Hospitals segment dominated the Surgical Glue Market due to their central role in performing the highest volumes of general, cardiovascular, and reconstructive surgery requiring adhesive-based closure and hemostasis. Large hospital networks continue running the highest procedure volumes globally, sustaining consistent adhesive and sealant demand. Continued investment in operating room efficiency and infection-control protocols reinforced this segment's dominant contribution to total market revenue throughout the base year, sustained by high-acuity surgical case mix.

The Ambulatory Surgical Centers segment is expected to witness the fastest growth in the Surgical Glue Market as outpatient facilities increasingly adopt fast-curing, room-temperature-stable adhesives suited to high-turnover procedure environments. Growing numbers of same-day surgical procedures increasingly rely on sutureless closure technology to shorten recovery time. Expanding ambulatory surgery infrastructure continues attracting a broadening base of facilities toward advanced adhesive adoption, as payers increasingly favor lower-cost outpatient surgical settings.

Regional Analysis

North America Surgical Glue Market Insights

North America dominated the Surgical Glue Market with the largest revenue share of approximately 41.5% in 2025. Robust healthcare infrastructure, high surgical procedure volumes, and the presence of major adhesive manufacturers continued reinforcing this dominant regional position. A deep concentration of leading medical device companies, ambulatory surgical centers, and academic medical centers headquartered across the continent gave regional surgeons early access to next-generation bioresorbable and room-temperature-stable adhesive platforms well ahead of most other regions, supported by favorable reimbursement pathways.

The United States accounted for the substantial majority of regional revenue, anchored by the high volume of minimally invasive and outpatient surgical procedures, alongside a significant concentration of ambulatory surgical centers driving demand for sutureless closure technology. Canada added further demand through its own growing surgical infrastructure and expanding day-surgery capacity, and that combined strength kept the continent the largest addressable market for surgical glue vendors through the forecast period.

Europe Surgical Glue Market Insights

Europe held a meaningful share of global revenue, supported by strong government support for healthcare modernization, growing adoption of advanced tissue adhesives, and continued collaborative research programs between hospitals and medical device firms across the region's major economies. Regulatory harmonization under the EU Medical Device Regulation and continued expansion of academic-industry research consortia continued lowering historically significant barriers to advanced adhesive technology adoption across the continent, particularly for synthetic formulations.

Germany led demand at roughly 21.20% of European revenue, supported by its substantial hospital infrastructure and medical device manufacturing base among the region's largest economies. The UK and France contributed substantial additional demand through their own well-funded surgical and cosmetic procedure volumes, and continued European investment in ambulatory care infrastructure and day-surgery capacity should keep regional demand for surgical glue climbing through the forecast period.

Asia Pacific Surgical Glue Market Insights

Asia Pacific is advancing at the fastest pace, growing at a CAGR of approximately 9.1% from 2026 to 2035. This growth is driven by expanding surgical volumes in China, Japan, and India, rising healthcare expenditure and growing government initiatives to strengthen domestic hospital infrastructure, with expanding ambulatory care networks and rising medical tourism volumes continuing to broaden the region's addressable surgical closure testing volume well beyond its traditional smaller base.

China held a substantial share of regional revenue, supported by product launches from major market players and rapid expansion of domestic hospital networks. India and Japan contributed meaningful additional demand, with India's growing medical tourism sector and Japan's advanced surgical infrastructure both reinforcing the region's position as the fastest-growing market tracked in this report, with all three countries expected to hold the major share of regional revenue through the remainder of the forecast period.

MEA and Latin America Surgical Glue Market Insights

The Middle East and Africa and Latin America both showed steady growth, driven by expanding hospital infrastructure, rising government investment in healthcare modernization, and growing demand for locally accessible surgical closure and cosmetic procedure capability across both areas. As these markets continued building out modern surgical infrastructure, surgical glue proved a genuinely efficient way to expand advanced wound closure capability without the decades-long buildout wealthier nations required, easing pressure on constrained hospital budgets.

Saudi Arabia led Middle East and Africa demand, supported by the country's substantial healthcare investment under its national healthcare transformation programs. The UAE contributed further demand through its own expanding private hospital network. In Latin America, Brazil accounted for the largest share of regional revenue, with growing cosmetic and general surgery adoption continuing to anchor regional demand for surgical glue across both public and private hospital networks.

Market Dynamics

Growth Drivers: Rising Surgical Procedure Volumes and Growing Minimally Invasive Surgery Adoption

The industry is driven by rising global surgical procedure volumes requiring fast and reliable wound closure, growing adoption of minimally invasive and robotic-assisted surgical techniques, increasing use of tissue adhesives in cosmetic and outpatient procedures, and expanding bioresorbable internal adhesive availability. As hospitals and ambulatory centers continue prioritizing shorter operating times and lower infection rates, the need for advanced surgical glue continues driving adoption across both inpatient and outpatient settings worldwide, reinforced by rising patient preference for scar-minimizing closure.

Rising clinical evidence supporting synthetic and bioresorbable adhesives over conventional sutures continues reinforcing this driver, as more surgeons adopt formulations that reduce operative time and improve wound aesthetics. Growing availability of room-temperature-stable sealants continues improving accessibility across ambulatory surgical centers, and that combination of formulation innovation and storage convenience is exactly what keeps demand climbing at such a steady, sustained pace across both established and emerging healthcare systems.

Restraints: High Product Costs and Regulatory Complexity for Internal-Use Adhesives

The substantial per-unit cost of advanced synthetic and bioresorbable surgical adhesives continues posing a genuine restraint on faster market-wide expansion, particularly across smaller hospitals and ambulatory centers without the procurement budgets that large hospital networks can commit. That cost profile has kept large-scale adoption of premium adhesive formulations concentrated among a comparatively small number of well-resourced surgical facilities, particularly in tertiary and academic hospital settings.

A persistent regulatory complexity surrounding internal-use adhesive approvals continues posing a further restraint, as demonstrating long-term biocompatibility and safety for internal tissue sealing requires extensive clinical evidence that delays product commercialization. That approval burden keeps some smaller manufacturers reliant on topical, externally applied formulations rather than pursuing internal-use surgical glue indications of their own, lengthening time to commercial launch.

Opportunities: Bioresorbable Internal Adhesives and Emerging Market Surgical Infrastructure

Rising investment in bioresorbable, internal-use adhesive formulations represents a genuinely significant opportunity, as surgeons increasingly seek technology capable of eliminating surgical drains and reducing complications following abdominoplasty, cardiovascular, and reconstructive procedures. Vendors positioned early in internal-use regulatory approval and polymer chemistry innovation stand to capture meaningful share as this capability continues expanding from specialized surgical applications into mainstream operating room workflows across multiple surgical specialties.

Closing surgical infrastructure gaps across emerging healthcare markets offers a second substantial opportunity, as rising healthcare expenditure and government initiatives supporting domestic hospital modernization continue creating fresh demand for accessible wound closure technology. Vendors with proven, cost-effective adhesive platforms stand to capture meaningful share as developing economies increasingly expand surgical capacity to support elective and emergency procedure growth at scale, particularly across secondary and tertiary cities.

Recent Developments:

• 2025: Merck KGaA reported clinical data on its combination fibrin sealant and proprietary hydrogel product, demonstrating reduced blood loss and operative time in liver resection surgery.

• 2026: Henkel launched Loctite Solve, an AI-powered platform that builds digital twins of adhesive formulations to simulate performance and speed translation of lab formulations into sterile, biocompatible surgical adhesives.

• August 2024: Resivant Medical received FDA 510(k) clearance for its Cutiva Topical Skin Adhesive and Cutiva PLUS Skin Closure System, pairing an adhesive mesh patch with a high-viscosity liquid adhesive.

Surgical Glue Market key players are:

• Baxter International Inc.

• Johnson & Johnson MedTech (Ethicon)

• B. Braun SE

• Medtronic plc

• Integra LifeSciences Holdings Corporation

• Advanced Medical Solutions Group plc

• Artivion, Inc.

• Becton, Dickinson and Company (BD)

• Cardinal Health, Inc.

• 3-D Matrix Medical Technology

• Merck KGaA

• Teleflex Incorporated

• Sanofi (GEM S.r.l.)

• Chemence Medical, Inc.

• Adhezion Biomedical, LLC

• Cohera Medical, Inc.

• Tricol Biomedical, Inc.

• Stryker Corporation

• Solventum (3M Medical Solutions Division)

• Vivostat A/S

Surgical Glue Market Report Scope: